What is the appropriate acute management for a patient presenting with suspected toxic megacolon characterized by marked colonic dilation, fever, tachycardia, hypotension, leukocytosis and peritoneal irritation?

Acute Management of Toxic Megacolon

Immediately initiate aggressive medical resuscitation while simultaneously consulting colorectal surgery on day of admission, because surgical delay is the single most important modifiable risk factor for mortality in this condition with perforation rates carrying 27–57% mortality. 1, 2

Immediate Medical Stabilization

Resuscitation and Supportive Care

• Make patient NPO and initiate parenteral nutrition to minimize colonic stimulation 2
• Aggressively resuscitate with intravenous fluids to correct dehydration and maintain hemodynamic stability 1, 2
• Transfuse packed red blood cells to maintain hemoglobin >10 g/dL 2
• Administer subcutaneous low-molecular-weight heparin for venous thromboembolism prophylaxis 1, 2

Pharmacologic Therapy

• Start high-dose intravenous corticosteroids immediately: hydrocortisone 100 mg IV every 6–8 hours OR methylprednisolone 60–80 mg IV daily 1, 2
• Initiate empiric broad-spectrum antibiotics covering enteric pathogens to prevent bacterial translocation and sepsis 1, 2
• Add oral vancomycin until Clostridioides difficile infection is excluded 1

Electrolyte Management (Critical)

• Aggressively correct hypokalemia and hypomagnesemia, as these electrolyte disturbances directly worsen colonic dilatation by impairing smooth muscle contractility 1

Medications to AVOID

• Do not administer opioids or antidiarrheal agents, as these precipitate further colonic dilatation and can trigger perforation 1

Intensive Monitoring Protocol

Clinical Assessment

• Perform focused abdominal examination at least four times daily, specifically assessing for worsening tenderness, rebound, guarding, or new peritoneal signs 2
• Record vital signs every 4–6 hours (more frequently if unstable), monitoring for fever >38.5°C, tachycardia, hypotension, or rigors 2, 3

Radiographic Surveillance

• Obtain daily plain abdominal radiographs to track colonic diameter (toxic megacolon defined as mid-transverse colon >5.5–6 cm) and detect free intraperitoneal air 2, 3
• The transverse colon is the segment at highest risk for perforation, unlike mechanical obstruction where the cecum is most vulnerable 1, 3
• Perform CT scanning if perforation is suspected, plain films are equivocal, or hemodynamic instability develops—CT detects free or contained perforation, colonic wall thickening, pericolonic fat stranding, and abscess formation 3

Laboratory Monitoring

• Repeat complete blood count, CRP/ESR, electrolytes, albumin, and liver function tests every 24–48 hours 2
• Monitor for marked leukocytosis (>15–20 × 10⁹/L), left shift (band neutrophils >20%), rising creatinine (>50% above baseline), elevated lactate, and hypoalbuminemia (<25 g/L)—all indicate severity and poor prognosis 3

Surgical Decision-Making Algorithm

ABSOLUTE Indications for IMMEDIATE Surgery

• Free colonic perforation (mortality 27–57%) 1, 2
• Massive gastrointestinal hemorrhage with persistent hemodynamic instability despite resuscitation 1, 2
• Clinical deterioration with shock: hypotension, tachycardia, organ hypoperfusion, or overt peritonitis 1, 2

RELATIVE Indications for URGENT Surgery (within 24–48 hours)

• No clinical improvement after 24–48 hours of optimal medical therapy 1, 2
• Persistent fever beyond 48–72 hours of steroid treatment (suggests occult perforation or abscess) 1, 2
• Progressive colonic dilatation on serial radiographs 1, 2
• Worsening laboratory markers: rising leukocyte count, increasing CRP, progressive metabolic acidosis 2
• Increasing transfusion requirements 1, 2
• Escalating abdominal pain or tenderness on serial examinations 2

Surgical Procedure of Choice

• Perform subtotal colectomy with end ileostomy, leaving a long rectal stump (either incorporated into the abdominal wound or exteriorized as mucous fistula) 1, 2
• This approach avoids rectal excision (reducing morbidity and mortality) and preserves the option for future restorative ileo-anal pouch reconstruction 1, 2

Rescue Medical Therapy Considerations

• Around day 3 of corticosteroid treatment, assess eligibility for rescue therapy with infliximab or cyclosporine in steroid-refractory disease 2
• This decision requires multidisciplinary discussion between gastroenterology and colorectal surgery 2
• Up to 80% of patients with acute severe colitis may respond to biologic rescue therapy, but prolonged immunosuppression increases morbidity and mortality if subsequent surgery becomes necessary 2
• Do not delay surgery while pursuing prolonged medical therapy—this markedly increases mortality 1

Multidisciplinary Coordination

• Immediate coordination between gastroenterology and colorectal surgery is mandatory from day of admission 1, 2
• Daily senior gastroenterology review and same-day surgical consultation ensure timely reassessment 1
• Frequent multidisciplinary reassessments continue until clear clinical improvement or definitive evidence of deterioration 1

Critical Pitfalls to Avoid

• Never perform colonoscopy in the setting of toxic megacolon—this can precipitate perforation 1
• Never delay surgery in critically ill patients or those failing medical therapy—surgical delay is the most important modifiable risk factor for mortality 2
• Never fail to correct electrolyte abnormalities—hypokalemia and hypomagnesemia perpetuate colonic dysmotility and worsen outcomes 1
• Never overlook C. difficile infection—there has been a marked increase in toxic megacolon cases associated with pseudomembranous colitis, and empiric oral vancomycin should be started until this is excluded 1, 4
• Never assume a negative CT excludes perforation—combine imaging with clinical assessment and laboratory findings 3